GlobeNewswire·Jun 8, 2026, 1:39 PM ET

Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026

Vivos Therapeutics, Inc. (NASDAQ: VVOS) announced its executive team will attend The Small Cap Showcase & WTR Insights on June 9, 2026, in New York City.
CEO Kirk Hunstman will deliver a corporate presentation at 11:30 am ET & participate in one-on-one meetings with pre-qualified investors.
The event features approximately 20 micro & small-cap companies across diverse industries for presentations, networking, & industry insights.
A live webcast of the presentation is available at Vivos Conference Webcast, with a replay accessible later via the company's Investor Relations section.
Vivos Therapeutics develops FDA-cleared diagnostic & treatment methods for breathing issues like obstructive sleep apnea (OSA) in adults & children ages 6 to 17.
The company's CARE devices are the only FDA 510(k) cleared technology for treating severe OSA in adults & the first cleared for moderate-to-severe OSA in children.
The Vivos Method offers a proprietary, nonsurgical, noninvasive, & nonpharmaceutical solution for OSA patients.
The press release includes a cautionary note regarding forward-looking statements, citing risks such as the potential inability to raise new equity, secure financings, or maintain Nasdaq listing status.